期刊文献+

纳米晶递药体系在肿瘤诊疗领域研究进展

Recent Advances of Nanocrystal Drug Delivery System for Tumor Diagnosis and Treatment
原文传递
导出
摘要 纳米晶材料因其独特的尺寸和优异的理化性能近年来备受关注,基于纳米晶理论和实践的研究,显示了其广阔的生物医学应用前景。重点简介纳米晶的定义、分类、制备及修饰工艺,综述多种纳米晶体系在肿瘤诊疗及临床应用中的研究进展,分析讨论纳米晶在生物应用时的体内过程和存在的技术问题,为基于纳米晶的递送体系在肿瘤诊疗领域进一步开发提供参考。 Nanocrystalline materials have attracted increasing attention due to their unique size and superior physicochemical properties,which enable their broad potential applications in the biomedical fields.The definition,category,preparation and modification of nanocrystals,with particular focus on the recent progress of nanocrystals utilized for tumor diagnosis,cancer treatment,and other medicinal applications are summarized.The fate of nanocrystals in vivo and current challenges in clinical translation are discussed.This review aims to provide insights for further development of nanocrystal delivery systems for tumor diagnosis and treatment.
作者 凌祥 李尚飞 龙威 杨宇涵 蔡挺 LING Xiang;LI Shangfei;LONG Wei;YANG Yuhan;CAI Ting(Department of Pharmaceutics,School of Pharmaceutical Science,China Pharmaceutical University,Nanjing 210009,China)
出处 《药学进展》 CAS 2022年第2期116-127,共12页 Progress in Pharmaceutical Sciences
基金 国家自然科学基金(No.81872813)。
关键词 纳米晶 制备修饰 诊疗 肿瘤 体内行为 nanocrystals preparation and modification diagnosis and treatment tumor in vivo fate
  • 相关文献

参考文献8

二级参考文献166

  • 1周湘颖,李佳俐,王亚敏,操锋.新剂型在眼部给药系统的应用进展[J].中国新药杂志,2020,29(1):55-62. 被引量:9
  • 2袁海龙,刘毅,赵艳玲,肖小河.Herpetin, a New Bioactive Lignan Isolated from Herpetospermum caudigerum[J].Journal of Chinese Pharmaceutical Sciences,2005,14(3):140-143. 被引量:5
  • 3Lipinski C. Poor aqueous solubility-an industry wide problem in drug discovery. American Pharmaceutical Review, 2002, 5:82-85.
  • 4Peters K, Muller R H. Nanosuspensions for the formulation of poorly soluble drugs I. Preparation by a size reduction technique. International Journal of Pharmaceutics, 1998, 160(2): 229-237.
  • 5Fromming K H S, Fromming J. Cyclodextrines in Pharmacy. Dordrecht: Kluwer Academic, 1993.
  • 6Muller R H. Dispersions for the formulation of slightly or poorly soluble drugs. US Patent, 7060285, 2001.
  • 7Muller B W, Rasenack N. Micro-size drug particles: Common and novel micronization techniques. Pharmaceutical Development and Technology, 2003, 9:1-13.
  • 8Zhang D, Chen M, Gao L. Drag nanocrystals for the formulation of poorly solubledrugs and its application as a potential drug delivery system. Journal of Nanoparticle Research, 2008, 10(5): 845-862.
  • 9Park J Y, Zhang Y, Liu F. Targeted cancer therapy with novel high drug-loading nanocrystals. Journal of Pharmaceutical Sciences, 2010, 99(8): 3542-3551.
  • 10Luna I P, Sntmdhar K B, Khatun S. Increasing possibilities of nanosuspension. Journal of Nanotechnology, 2013, 346581:1-12.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部